Read More Pharma Industry News Sumitovant Biopharma to take full ownership of Myovant Sciences for $1.7bn Sumitovant Biopharma, a subsidiary of Japan-based Sumitomo Pharma (previously Sumitomo Dainippon Pharma), is set to take full ownership… byPallavi MadhirajuOctober 24, 2022